PMO Interview with the Innovator Series: Volume 7

Video Categories: PMO Interview with the Innovator Series

Listen as some of the top academic and community thought leaders in multiple myeloma define what precision medicine means to them.
September 2, 2015

Treatment Regimen for Patients with Multiple Myeloma

Dixie-Lee Esseltine, MD and George Mulligan, PhD explain ixazomib’s mechanism of action and how the drug may fit into the treatment regimen for patients upon approval and beyond.

March 31, 2015

Beginnings of Personalized Medicine for Myeloma

Dr. Ajai Chari talks about risk-based treatment for myeloma as the beginning of personalized medicine in the field. The 2 most recent advances are the increased use of proteasome inhibitors for those with the 4;14 translocation and treating those identified with high molecular risk more aggressively.